Study of Oral Venetoclax Tablets to Evaluate Adverse Events and Change in Disease Activity in Participants Above 19 Years of Age With Acute Myeloid Leukemia (AML)

RecruitingOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

April 5, 2021

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Acute Myeloid Leukemia (AML)
Trial Locations (10)

21565

RECRUITING

Gachon University Gil Medical Center /ID# 239008, Incheon

41944

RECRUITING

Kyungpook National University Hospital /ID# 257398, Daegu

42415

COMPLETED

Yeungnam University Medical Center /ID# 239007, Daegu

49241

RECRUITING

Pusan National University Hospital /ID# 239010, Busan

49267

RECRUITING

Kosin University Gospel Hospital /ID# 257399, Busan

58128

RECRUITING

Chonnam National University Hwasun Hospital /ID# 257478, Hwasun-gun

02841

RECRUITING

Korea University Anam Hospital /ID# 231022, Seoul

03080

RECRUITING

Seoul National University Hospital /ID# 257477, Seoul

06351

RECRUITING

Samsung Medical Center /ID# 239009, Seoul

03722

RECRUITING

Yonsei University Health System Severance Hospital /ID# 239006, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY